Certain products of glioma cells have been associated with DC dysfunction, including 2‐hydroxyglutarate (2‐HG), fibrinogen‐like protein 2 (FGL2),38 Nrf2, and thymic stromal lymphopoietin (TSLP) dehydrogenase. Here, NFE2L2 is linked to central nervous system cancer.